Beryllium Documents
The following documents are referenced in a Letter to the Editor by David Michaels and Celeste Monforton (Public Health Reports (PHR), July-August 2008) responding to a Letter to the Editor by Brush Wellman's Marc Kolanz (PHR same issue).
1. Michaels D, Monforton C. Beryllium’s public relations problem: protecting workers when there is no safe exposure level. Public Health Rep 2008;1:79-88. (here)
2. Michaels D. Doubt is their product: how industry’s assault on science threatens your health. New York: Oxford University Press; 2008.
3. DefendingScience.org. Beryllium documents (this page)
4. Rozek B. Memorandum to R.A. Foos. Subject: forecast of sales 1978–1985. 1977 Oct 18.
5. Brush Wellman briefing outline on OSHA. 1977. Bates No. BF 009662.
6. Charter of Beryllium Industry Scientific Advisory Committee. Introduction. 1993, Bates No. BF 0010985.
7. Hanes H. Memorandum to Bill Taylor. Subject: IARC project. 1998 Aug 21. Bates No. BD 303520.
8. Roe S. Deadly alliance: how government and industry chose weapons over workers. The [Toledo] Blade 1999 Mar 28.
9. ABC News, 20/20. The deadly dust: thousands of nuclear weapons workers exposed to beryllium dust are sick or dying. 2000 Apr 19.
10. Bingham E. Letter to Julius Richmond, Assistant Secretary for Health, Department of Health, Education & Welfare. 1978 Mar 8.
11. Discher DP. Letter to William H. Foege, Director, Center for Disease Control. 1978 Oct 13.
12. Levy PS, Roth HD, Hwang PM, Powers TE. Beryllium and lung cancer: a reanalysis of a NIOSH cohort mortality study. Inhal Toxicol 2002;14:1003-15. (PubMed abstract)
13. Levy PS, Roth HD, Deubner DC. Exposure to beryllium and occurrence of lung cancer: a reexamination of findings from a nested case-control study. J Occup Environ Med 2007;49:96-101. (PubMed abstract)
14. Deubner DC, Roth HD, Levy PS. Empirical evaluation of complex epidemiologic study designs: workplace exposure and cancer. J Occup Environ Med 2007;49:953-9. (PubMed abstract)
15. Steenland K, Ward E. Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J Natl Cancer Inst 1991;83:1380-5.
16. Ward E, Okun A, Ruder A, Fingerhut, Steenland K. A mortality study of workers at seven beryllium processing plants. Am J Ind Med 1992;22:885-904. (PubMed abstract)
17. Sanderson WT, Ward EM, Steenland K, Petersen MR. Lung cancer case-control study of beryllium workers. Am J Ind Med 2001;39:133-44. (PubMed abstract)
18. Brown SC, Schonbeck MF, McClure D, Baron AE, Navidi WC, Byers T, et al. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: a case-control study. Am J Epidemiol 2004;160:163-72.
19. Schubauer-Berigan MK, Deddens JA, Steenland K, Sanderson WT, Peterson MR. Adjustment for temporal confounders in a reanalysis of a case-control study of beryllium and lung cancer. Occup Environ Med 2007 Sep 21. (PubMed abstract)
20. Schubauer-Berigan MK, Deddens JA, Petersen MR. Re: Exposure to beryllium and occurrence of lung cancer: a reexamination of findings from a nested case-control study. J Occup Environ Med 2007;49:708-9. (No abstract)
21. Langholz B, Richardson D. Empirical evaluation of complex epidemiologic study designs: workplace exposure and cancer. J Occup Environ Med 2008;50:1-2; author reply 2-3. (No abstract)
22. International Agency for Research on Cancer. Monograph: beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Lyon (France): IARC; 1993.
23. Department of Health and Human Services, National Toxicology Program (US). Tenth report on carcinogens. 2002.
24. Rogers AE. Statement of Adrianne E. Rogers, on behalf of Brush Wellman, Inc. at OSHA Public Hearing on Proposed Standard on Beryllium. 1977 Jul 28. Bates No. D 303089.
25. Powell WS, Director of Sales and Marketing, Brush Wellman, Inc. Letter to Vortex Inc., September 20, 1989. Bates No. BF 0011502.
26. Beryllium Industry Scientific Advisory Committee. Draft of BISAC Meeting Minutes, June 30-July 1, 1992, as revised July 28, 1992. Bates No. NGK-IL-05398.
27. Hanes H. Memorandum to Bob Rozek, Subject: Activity Report Environmental and Government Affairs. July 23, 1992. Bates No. BD 113880.
28. Egilman D, Bagley S, Connolly S. Anything but beryllium: the beryllium industry’s corruption of safety information. Am J Ind Med 2002;42:270-1.
29. Emly M. Memorandum to Hugh Hanes. Subject: Potential sulfuric acid emissions at the Lorain facility, April 20, 1995.
30. Beryllium Industry Scientific Advisory Committee (BISAC). Draft Minutes of January 1996, BISAC Meeting, Key Largo, Florida. Bates No. NGK-IL-05974.
31. Beryllium Industry Scientific Advisory Committee. Is beryllium carcinogenic in humans? J Occup Environ Med 1997;39:205-8. (No abstract)
32. Kolanz ME, Roth HD. Comments of Brush Wellman, Inc. on the Draft Report on Carcinogens Background Document for Beryllium and Beryllium Compounds prepared for the National Toxicology Board of Scientific Counselors, January 6, 2000.
33. National Research Council. Health effects of beryllium exposure: a literature review. Washington: National Academies Press; 2007.
34. Stange AW, Furman FJ, Hilmas DE. The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance. Am J Ind Med 2004;46:453-62. (PubMed abstract)
35. Silveira L, Bausch M. Mroz M, Maier L, Newman L. Beryllium sensitization in the “general population.” Sarcoidosis Vasc Diffuse Lung Dis 2003;20:157. (Abstract)
36. Donovan EP, Kolanz ME, Galbraith DA, Chapman PS, Paustenbach DJ. Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program. Int Arch Occup Environ Health 2007;81:165-78. (PubMed abstract)
37. Borak J, Woolf SH, Fields CA. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment. J Occup Environ Med 2006;48:937-47. (PubMed abstract)
38. Cher DJ, Deubner DC, Kelsh MA, Chapman PS, Ray RM. Assessment of the beryllium lymphocyte proliferation test using statistical process control. Inhal Toxicol 2006;18:901-10. (PubMed abstract)
39. Kreiss K, Day GA, Schuler CR. Beryllium: a modern industrial hazard. Annu Rev Public Health 2007;28:259-77. (PubMed abstract)
40. J Occup Environ Med Errata 2006;48:1334.
41. Pappas GP, Newman LS. Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis 1993;148:661-6. (PubMed abstract)
42. Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect 1996;104 Suppl 5:953-6.
43. Hardy HL. The disability found in persons exposed to certain beryllium compounds. AMA Arch Ind Health 1955;12:174-81.
44. Occupational Safety and Health Administration, Department of Labor. Occupational Exposure to Cadmium, Final Rule. 1992; 57 Federal Register 42389.
45. Occupational Safety and Health Administration, Department of Labor. Occupational Exposure to Formaldehyde, Final Rule. 57 Federal Register 22290.
46. Occupational Safety and Health Administration, Department of Labor. Occupational Exposure to Lead, Final Rule. 1978; 43 Federal Register 52952.
47. Eisenbud M. An environmental odyssey: people, pollution, and politics in the life of a practical scientist. Seattle: University of Washington Press; 1991.
48. Department of Energy (US). Chronic Beryllium Disease Prevention Program. 64 Federal Register 68854, December 8, 1999.
49. Gibson PR, Vice President, Hill and Knowlton. Letter to James E. Gulick, Vice President, Investor Relations and Corporate Development, attaching “monthly invoice for our services,” November 18, 1986. Bates No. D 096095.
50. Gulick JE. Memorandum to Brush Executives. Subject: Hill & Knowlton – Environmental Public Relations, February 23, 1989. Bates No. WM 033483.
51. Davis RC. Memorandum SUBJECT: Hill and Knowlton Beryllium PR Program, April 21, 1989.
52. Davis RC. Letter to David Kalson, Hill and Knowlton, Subject: Supporting Information for PR Program, April 3, 1989. Bates No. D-404112.
53. Marder H, Hill and Knowlton. Memorandum to Rob Rozek, Brush Wellman, May 1, 1989.
54. Davis RC. Memorandum to Distribution List, SUBJECT: Defense Logistics Agency Beryllium Oxide Hazmat Program, July 12, 1989. Bates No. WM 51506.
55. Davis RC. Memorandum to Distribution List, Subject: DLA Beryllium Oxide HAZMAT Program, August 9, 1989. Bates No. WM 051514.
